The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Hanauer, Stephen
One or more keywords matched the following items that are connected to Hanauer, Stephen
Item TypeName
Concept Treatment Outcome
Academic Article Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
Academic Article A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells.
Academic Article Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.
Academic Article Cyclosporin for severe ulcerative colitis: a user's guide.
Academic Article Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.
Academic Article No butts about it: put the fire out by lighting up.
Academic Article A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
Academic Article Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group.
Academic Article Infliximab for the treatment of fistulas in patients with Crohn's disease.
Academic Article Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group.
Academic Article Side-to-side isoperistaltic strictureplasty in extensive Crohn's disease: a prospective longitudinal study.
Academic Article Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.
Academic Article Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.
Academic Article Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double-blind studies.
Academic Article Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Academic Article Crohn's disease: step up or top down therapy.
Academic Article First two patients with ulcerative colitis who developed classical thrombotic thrombocytopenic purpura successfully treated with medical therapy and plasma exchange.
Academic Article Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
Academic Article Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.
Academic Article Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials.
Academic Article Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Academic Article Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.
Academic Article The state of the art in the management of inflammatory bowel disease.
Academic Article Review article: aminosalicylates in inflammatory bowel disease.
Academic Article Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.
Academic Article Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies.
Academic Article Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
Academic Article Natalizumab induction and maintenance therapy for Crohn's disease.
Academic Article Emerging biologic therapies in inflammatory bowel disease.
Academic Article Semantics.
Academic Article Clinical perspectives in Crohn's disease. Turning traditional treatment strategies on their heads: current evidence for "step-up" versus "top-down".
Academic Article A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis.
Academic Article Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
Academic Article Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study.
Academic Article The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
Academic Article Refining the role of TNF antagonists for Crohn's disease. Introduction.
Academic Article Randomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort.
Academic Article Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
Academic Article Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease.
Academic Article A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
Academic Article Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 Study.
Academic Article Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty.
Academic Article Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.
Academic Article Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
Academic Article Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.
Academic Article Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Academic Article Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
Academic Article Maintenance therapy with certolizumab pegol for Crohn's disease.
Academic Article An evidence-based systematic review on medical therapies for inflammatory bowel disease.
Academic Article Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.
Academic Article Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.
Academic Article Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial.
Academic Article Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
Academic Article Complications of peristomal recurrence of Crohn's disease: a case report and a review of literature.
Academic Article Disease modification in inflammatory bowel disease.
Academic Article Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.
Academic Article What changes in inflammatory bowel disease management can be implemented today?
Academic Article Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
Academic Article Management of inflammatory bowel disease: past, present and future.
Academic Article Assessing response and loss of response to biological therapies in IBD.
Academic Article Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Academic Article The case for using 5-aminosalicyclates in Crohn's disease: pro.
Academic Article Treatment of Crohn's disease: the "long" of it.
Academic Article Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study.
Academic Article The management of ulcerative colitis.
Academic Article Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
Academic Article Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study.
Academic Article Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.
Academic Article Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
Academic Article Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
Academic Article Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.
Academic Article A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
Academic Article Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial.
Academic Article Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
Academic Article Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study.
Academic Article Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Academic Article Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Academic Article Intravenous cyclosporin in ulcerative colitis: a five-year experience.
Academic Article Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.
Academic Article A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Academic Article Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials.
Academic Article Design issues and outcomes in IBD clinical trials.
Academic Article Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
Academic Article Parallel universes.
Academic Article Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
Academic Article Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's disease.
Academic Article Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.
Academic Article Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies.
Academic Article Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.
Academic Article Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
Academic Article Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
Academic Article Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.
Academic Article Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study.
Academic Article Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease.
Academic Article Heading back to the trough (levels of biologics in IBD).
Academic Article Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.
Academic Article Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial.
Academic Article A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.
Academic Article AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study.
Academic Article Oral or Topical 5-ASA in Ulcerative Colitis.
Academic Article Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
Academic Article Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
Academic Article Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
Academic Article Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis.
Academic Article Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
Academic Article Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.
Academic Article Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Academic Article Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
Academic Article Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
Academic Article Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
Academic Article Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis.
Academic Article Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia.
Academic Article IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
Academic Article Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis.
Academic Article Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.
Academic Article Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial.
Academic Article Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
Academic Article Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Academic Article Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial.
Academic Article Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
Academic Article A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis.
Academic Article Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
Search Criteria
  • Treatment Outcome